GENERAL GENOMICS
DNA Empowered Healthcare
Improving patient outcomes with next-generation
A.I. powered medicine.

Imagine having the tools to not only predict but to proactively target individualized patient risks.
Early detection means better outcomes for everyone.
In traditional healthcare, providers and individuals have difficulty making fully informed health and health-related financial decisions based upon individualized risks. This causes concerns about making the most appropriate decisions about treatments, lifestyle, and overall patient care.
OUR APPROACH
People are 99.9% the same.
The Curo46 system utilizes health history and genetics with our proprietary artificial intelligence to understand individuals’ risk for disease, illness, or treatment side effects. Our unique algorithms analyze millions of variables across millions of records identifying complex relationships and meaningful patterns. The Curo46 system is designed to determine risks of specific illnesses with 80% accuracy (based on current models).

Patient-Focused
By focusing on the patient, the Curo46 System is able to accurately predict risks such as “Return To Hospital” and other significant risks.
Specific and Targeted
Identification of targeted individual risks provides data for improved patient health/treatment strategies.
Lower Costs!
New insights into illnesses and treatments. Reduced time for treatment analysis. Reduced overall health-care costs
Area of Focus
Healthcare Providers
Predictive algorithms for hospitals, long-term care facilities, and more. Used to improve care responsiveness and improve operational decisions around patients that are “at-risk” — including risk of returning to a hospital for LTCs, a $20 billion annual cost.
Medical & Health Research
Aiding medical research facilities to gain more significant insights into their data using our ML/AI algorithms and extensive medical database.
Personal Electronic Medical Records. (PEMR)
An anonymized health and medical history repository allows individuals control over their own health, medical, and genetic information.
Symptom Tracker
Easy to use interface developed for both Individuals and healthcare providers to track symptoms as they occur, providing professinals and our algorithms more accurate information then has previously been available.
Looking Towards the Future
Universal Electronic Medical Records. (UEMR)
Individuals, Professionals and Institutions can seemlessly share and exchange medical and health history.
5D Imaging
Conventional radiology display uses grayscale 2D slices or 3D with no transparency. Our ground-breaking Curo5D technology uses ray casting with transparency and image density .
Team

AJ Rosenthal
President
B.S., Nuclear Engineering Technologies, MBA, Finance; US Navy Nuclear Engineer; A corporate career in science and sales for energy industry

Warren Gieck
B.S., Engineering and A.I. Expert Led AI-driven digital transformations at global leaders GE and B. Hughes. Robotics and industrial automation expert – built GE’s Adaptix

Caleb Stuart
B.S. & J.D. Owner of the Stuart Law Firm US Marine Corps Commercial litigation specialty
Strategic Partners & Research Institutions


FEATURED IN

7 Texas, United States Based Bioinformatics Companies | The Most Innovative Bioinformatics Companies
At Best Startup Texas we track over 100,000 Texan startups and over 500,000 people who hold key positions in these companies. We use this directory of startups

Startup Innovator of the Year Finalist
405 Business Startup Innovator of the Year Finalist – General Genomics

Moleculera Labs and General Genomics Form Strategic Alliance to Utilize Proprietary AI to Provide Personalized Medicine for Autoimmune Neuropsychiatric Disorders
By AIT News Desk On Jul 26, 2022 Moleculera Labs, Inc. (Moleculera) and General Genomics, Inc. (GGI) announce the formation of a strategic alliance between

Personalizing Healthcare Through Data With General Genomics
by Ditsa Keren General Genomics is a bioinformatics artificial intelligence platform that provides customers with a comprehensive analysis of disease susceptibility and treatment effectiveness. In this
Warren Gieck Honored With The “Excellence In Technology” Award At InterCon Las Vegas, 2021
Las Vegas, Nevada — June 28, 2021 — Warren Gieck, Co-Founder at General Genomics Inc., was honored with the prestigious “Excellence in Technology” award for his significant

69 Most Innovative Texas Based Predictive Analytics Companies
Written by Mark Smith Navigate the Article show This article showcases our top picks for the best Texas based Predictive Analytics companies. These startups and companies are

69 Best Predictive Analytics Startups in Texas of 2021
Written by Warren Tesla This article showcases our top picks for the best Texas based Predictive Analytics companies. These startups and companies are taking a variety

Midlander creates algorithm to predict likelihood of infection
Determination would be made using person’s genetic make-up, medical history by Caitlin Randle, MRT.com/Midland Reporter-Telegram – April 16, 2020 A Midland data scientist and his two

101 Of The Hottest Apps and App Development Startups To Keep An Eye On In 2020
Written by hassan This article showcases Startup Pill’s top picks for the best app development startups. These startups are taking a variety of approaches to innovating